XWXiao-Qi Wang
Xiao-Qi Wang
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiao-Qi Wang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jianyun Lu
Department of Dermatology, Third Xiangya Hospital, Central South University
2 shared publications - Jinrong Zeng
Department of Dermatology, the Third Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Lihua Gao
Departments of Dermatology The Third Xiangya Hospital, Central South University Changsha China
2 shared publications - Yaping Xiang
Department of Dermatology, The Third Xiangya Hospital Central South University Changsha Hunan China
2 shared publications - Zhi-Bing Fu
Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China
2 shared publications - Amy S. Paller
Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois USA
1 shared publication
Latest Publications
- 7 June 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (12) , 2507-2514.e6
Topical Ozone Accelerates Diabetic Wound Healing by Promoting Re-Epithelialization through the Activation of IGF1R–EGFR Signaling
- 7 June 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (12) , 2507-2514.e6
Topical Ozone Accelerates Diabetic Wound Healing by Promoting Re-Epithelialization through the Activation of IGF1R–EGFR Signaling
- 8 February 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (9) , 2476-2487.e9
Increased IRF9–STAT2 Signaling Leads to Adaptive Resistance toward Targeted Therapy in Melanoma by Restraining GSDME-Dependent Pyroptosis
- 8 February 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (9) , 2476-2487.e9
Increased IRF9–STAT2 Signaling Leads to Adaptive Resistance toward Targeted Therapy in Melanoma by Restraining GSDME-Dependent Pyroptosis